What Is PeptaHub and What Does It Offer?

Updated

PeptaHub (peptahub.com) is a peptide reference site that organizes evidence-based profiles of individual peptides alongside category hubs, comparison pages, and a regulatory status tracker. It is aimed at readers who want a structured starting point on a specific peptide or peptide class — mechanisms, research context, reported study ranges, risks, and regulatory status — with citations to peer-reviewed sources rather than a single editorial summary. It is a reference and research-context resource, not a source of personal medical advice or a place to obtain products.

What's on the site

The homepage describes the core scope as 156 profiles across 10 categories, supported by 500+ sources, with each profile described as covering mechanisms, research context, risks, and regulatory status.

Element What it contains
Profiles 156 individual peptide entries, each with a mechanism summary, research context, reported study ranges, risks, and regulatory status
Categories 10 categories spanning areas such as weight loss, recovery, longevity, immune, skin & beauty, and muscle & growth
Editorial hubs 7 hubs grouping peptides by class or purpose
Comparisons Head-to-head pages such as BPC-157 vs TB-500, Semaglutide vs Tirzepatide, Retatrutide vs Tirzepatide, Ipamorelin vs Sermorelin
Regulatory tracker Per-compound regulatory status, plus an FDA regulatory timeline covering 2023 to 2026
Tools A tools section linked from the homepage

The editorial hubs

Hubs are the fastest way to browse if you know the class you're interested in rather than a specific compound. The homepage lists these with profile counts:

  • GLP-1 Peptides — 29 profiles, covering semaglutide, tirzepatide, retatrutide, liraglutide, dulaglutide and others, compared by mechanism, FDA status, and clinical evidence
  • GH Secretagogues — 27 profiles
  • Nootropic Peptides — 25 profiles
  • Immune Peptides — 24 profiles
  • Longevity Peptides — 23 profiles
  • Skin Peptides — 23 profiles
  • Recovery Peptides — 9 profiles

Example profiles

The homepage's editor's picks illustrate the format and the level of sourcing per entry:

  • BPC-157 (Recovery) — described as a synthetic pentadecapeptide of 15 amino acids with the sequence GEPPPGKPADDAGLV, derived from a protective protein sequence found in human gastric juice; cited to 7 peer-reviewed sources
  • TB-500 (Recovery) — described as the synthetic research form of an actin-binding fragment of thymosin beta-4, a 43-amino-acid peptide originally isolated from calf thymus tissue; cited to 6 peer-reviewed sources
  • Semaglutide (Weight Loss) — described as a long-acting synthetic analog of GLP-1, an incretin hormone secreted by intestinal L-cells in response to food intake; cited to 5 peer-reviewed sources

Other picks listed include tirzepatide and retatrutide (weight loss), GHK-Cu (skin & beauty), CJC-1295 and ipamorelin (muscle & growth), MOTS-c (longevity), and thymosin alpha-1 (immune).

Comparison and regulatory pages

If your question is "which of these two, and on what basis," the comparison pages put compounds side by side. The site lists, among others:

  • BPC-157 vs TB-500 (recovery)
  • Semaglutide vs Tirzepatide, Retatrutide vs Tirzepatide, Survodutide vs Tirzepatide (GLP-1)
  • TB-500 vs Thymosin beta-4 (naming)
  • BPC-157 vs MGF, TB-500 vs IGF-1 LR3 (recovery)
  • Ipamorelin vs Sermorelin (GH)

For regulatory questions, the site provides a per-compound status tracker and an FDA regulatory timeline spanning 2023 to 2026, plus a "regulatory news" entry point.

Who it suits, and what to check before relying on it

PeptaHub fits readers who want a consolidated, source-linked overview before digging into primary literature: researchers orienting themselves in an unfamiliar peptide class, or anyone trying to understand what a compound is, what has been studied, and where it stands regulatorily.

Two practical caveats:

  1. Verify the primary sources. The site states profiles are sourced from peer-reviewed research and lists a source count per profile. For anything you intend to act on or cite, follow the linked sources rather than relying on the summary alone.
  2. Treat "reported study ranges" as reported, not recommended. The site's own framing distinguishes research context and reported ranges from guidance. Nothing on a reference site substitutes for a qualified professional's assessment of your situation.

The homepage does not display pricing, account requirements, or access restrictions, so whether any content sits behind a login or paywall isn't determinable from the material available here — check directly on the site if that matters to you.